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Abstract
There is an increasing demand for synthetic scaffolds with the requisite biocompatibility,
internal architecture, and mechanical properties for the bone repair and regeneration. In this work,
scaffolds of a silicate bioactive glass (13-93) were prepared by a freeze extrusion fabrication
(FEF) method and evaluated in vitro for potential applications in bone repair and regeneration.
The process parameters for FEF production of scaffolds with the requisite microstructural
characteristics, as well as the mechanical and cell culture response of the scaffolds were
evaluated. After binder burnout and sintering (60 min at 700°C), the scaffolds consisted of a
dense glass network with interpenetrating pores (porosity ≈ 50%; pore width = 100−500 µm).
These scaffolds had a compressive strength of 140 ± 70 MPa, which is comparable to the
strength of human cortical bone and far higher than the strengths of bioactive glass and ceramic
scaffolds prepared by more conventional methods. The scaffolds also supported the proliferation
of osteogenic MLO-A5 cells, indicating their biocompatibility. Potential application of these
scaffolds in the repair and regeneration of load-bearing bones, such as segmental defects in long
bones, is discussed.
Keywords: Freeze extrusion fabrication; bioactive glass; solid freeform fabrication; bone repair
*Corresponding author. E-mail: hts@mst.edu (T.S. Huang)
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1. Introduction
There is an increasing demand for synthetic scaffolds with the requisite biocompatibility,
mechanical properties and internal architecture for the repair and regeneration of tissues and
organs. An ideal scaffold for bone repair and regeneration should have the following
characteristics [1]: (1) biocompatible (non-toxic) with the ability to promote cell adhesion,
proliferation, and differentiation; (2) porous three-dimensional (3D) architecture to allow cell
proliferation, vascularization, and diffusion of nutrients between the cells seeded within the
matrix and the surroundings; (3) mechanical properties comparable to the bone to be replaced; (4)
ability to bond firmly to bone and soft tissue; (5) degradation rate similar to the rate at which
new bone is formed; (6) processability into the desired anatomical shape.
Bioactive glass has several attractive properties for application as a scaffold material
[2,3]. Bioactive glass reacts with the body fluids, forming a surface layer of hydroxyapatite (the
main mineral constituent of bone) which is responsible for forming a firm bond with hard and
soft tissues. Bioactive glass is osteoconductive as well as osteoinductive, and has a widely
recognized ability to support new bone growth. However, porous bioactive glass scaffolds
fabricated using conventional methods commonly have low strength (<20 MPa) [3,4], so their
use in the repair and regeneration of load-bearing bones is challenging. Attempts are currently
being made to improve the mechanical properties of bioactive glass scaffolds for the repair of
load-bearing bones [4-6]. These attempts are focused mainly on the control of the pore shape,
pore size, and pore orientation to improve the strength of the scaffolds.
Solid freeform fabrication (SFF) can potentially produce scaffolds with customized
external shape, as well as predefined and reproducible internal architecture (porosity; pore size;
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and pore distribution). An advantage of the SFF technology is the potential ease of creating
scaffolds with the anatomical shape and dimensions tailored specifically to individual patients.
SFF technologies involve building three-dimensional (3D) objects layer by layer. Although there
are several variants of SFF technology, the general process involves producing a computergenerated model, which represents the physical prototype to be built, using computer-aided
design (CAD) software. The model is next converted into a format that is analyzed by a
computer, which slices the model into cross-sectional layers. The data is then implemented to the
SFF machine which systematically produces the physical prototype layer by layer. Postprocessing of the formed article is often necessary to remove temporary support structures or
processing aids, particularly in the case of ceramic and glass particles that are commonly
difficult to bond directly by most available SFF techniques.
The most widely researched SFF techniques include fused deposition modeling (FDM) of
polymeric materials [7,8], fused deposition of ceramics (FDC) [9-11], selective laser sintering
(SLS) [12,13], 3-D printing [14], stereolithography [15], and robocasting [16]. Freeze extrusion
fabrication (FEF) has received less attention, but the technique has been used to fabricate dense
ceramic articles for mechanical engineering applications [17]. FEF is based on a combination of
techniques taken from fused deposition, freeze casting, and robocasting [18]. In FEF, an aqueous
mixture with a paste-like consistency is extruded through and orifice to form filaments, which
are frozen in situ to avoid slumping or distortion of the formed article. The rheology of the paste
is critical for providing the plastic properties required for avoiding flaws in the formed article.
After formation by FEF, the article is subjected to a freeze-drying step to sublime the frozen
liquid.
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In FEF of ceramic or glass, particles are commonly mixed with a polymeric binder phase
to provide the required plastic properties for extrusion. FEF of these materials involve key postprocessing steps. Following freeze drying to remove the frozen liquid, a binder removal step is
necessary prior to a sintering step in which the particles are thermally bonded to form a strong
network. Ideally, the binder phase used to impart the plasticity to the extrudate must be removed
completely (typically by thermal decomposition) prior to the onset of the sintering step to avoid
the presence of impurity phases in the final article. In the sintering step, the article is heated to a
sufficiently high temperature to cause matter transport in order to bond the particles into a dense
strong network. In the case of ceramics, the sintering temperature is typically 0.5−0.9 of the
melting temperature, whereas the sintering temperature is typically between the glass transition
temperature and the melting temperature for glass.
In the last decade, SFF methods have been widely applied to the production implants and
scaffolds for biomedical applications. The biomaterials used in these studies have been mainly
biodegradable polymers such as poly(glycolic acid), poly(lactic acid) and their copolymers, bioinert metals such as titanium, and bioactive ceramics such as hydroxyapatite [19-28]. There is
growing interest in the production of bioactive ceramics and bioactive glass scaffolds for
potential bone repair applications because their attractive properties.
The objective of this work was to evaluate the feasibility of forming bioactive glass
scaffolds using an FEF technique. The development of extrudable paste with optimized rheology
and the process parameters for the production of scaffolds with pre-determined internal
architecture were studied. A silicate bioactive glass designated 13-93 was used in this work
because of our previous experience with forming scaffolds of this glass using more conventional
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techniques. Products of 13-93 bioactive glass are also approved for in vivo use in the United
States, Europe, and elsewhere [29].

2. Experimental Procedures
2.1. Preparation of starting materials and extrudable paste
The bioactive glass used in this work is designated 13-93, with the composition (wt%):
53.0 SiO2, 6.0 Na2O; 12.0 K2O; 6.0 MgO, 20.0 CaO; 4.0 P2O5. Coarse particles of the glass were
kindly provided by Mo-Sci Corp., Rolla, Missouri. The as-received glass particles were ground
to a size finer than ∼3 µm, using a combination of two methods. Particles of size smaller than 45
µm were first obtained by grinding the as-received particles in a steel shatterbox (SPEX
SamplePrep LLC, Metuchen, NJ) and sieving the particles through a 325 mesh sieve.
Approximately 100 g of these particles were then dispersed in deionizedwater and ground for 1 h
in an attrition mill (Model 01-HD, Union Process, Akron, OH) using ZrO2 grinding media. After
evaporation of the water from the attrition-milled slurry using a hot plate, the particles were dried
for 24 h in oven at 65°C. The dried, agglomerated powder was ground in an agate mortar and
pestle, and sieved through a 325 mesh sieve.
An extrudable paste for use in the FEF process was prepared as follows. First, an
aqueous-based slurry with the composition given in Table I, consisting of glass particles,
deionized water, and polymeric additives, was formed into a homogeneous mixture by ball
milling for 24 h using Al2O3 milling media. These polymeric additives were selected because
they were used previously in the fabrication of Al2O3 articles by the FEF method [18]. Second,
the ball-milled slurry was heated under a controlled temperature/time schedule (70 min at 65°C)
to evaporate some of the water, and to control the viscosity of the paste. Pastes with different
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viscosities were tested in the FEF equipment to determine whether they were extrudable, and the
system with the optimum viscosity for extrusion was chosen by a trial-and-error method.

Table I. Composition of starting slurry used in the preparation of the extrudable paste for FEF.
Component

Concentration (vol%)

Function

Manufacturer

13-93 glass particles

40.00

Solid phase

Mo-Sci Corp., Rolla, MO

EasySperse

0.50

Dispersant

ISP Technologies, Inc., Wayne, NJ

Surfnol

0.50

Defoamer

Air Products & Chemicals, Inc., Allentown, PA

Glycerol

1.00

WCCA*

Alfa Aesar, Ward Hill, MA

PEG 400

1.00

Lubricant

Alfa Aesar, Ward Hill, MA

Aquazol 5

4.00

Binder

ISP Technologies, Inc., Wayne, NJ

Deionized water

53.00

Solvent

—

*WCCA: Water crystallization control agent
2.2 Freeze extrusion fabrication of bioactive glass scaffold
Figure 1 shows images of the main components of the FEF equipment used in this work.
The paste to be extruded is loaded into a heated reservoir housed in a computer-controlled gantry
that allows programmable movement in three dimensions. A nozzle attached to the reservoir
determines the diameter of the extrudate which is deposited on a fixed platform cooled to the
required temperature using liquid nitrogen. The system is contained within a cooled chamber.
In the present work, the fabrication environment temperature was −20°C. The paste was
extruded layer by layer, with each layer deposited at 90° relative to the preceding layer. Based on
the rheology of the paste, the software in the FEF machine was adjusted to control the extrusion
force and rate of deposition. A nozzle diameter of 580 µm was used in these experiments, and
the spacing between adjacent filaments was 600 µm.
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Figure 1. Images showing the main components of the freeze extrusion fabrication equipment
used in the present work.
2.3. Post processing of as-formed FEF construct
The decomposition kinetics of the polymeric binder (without glass particles) were
followed using thermogravimetric analysis (STA409, NETZSCH). Based on these kinetic data, a
temperature−time schedule was developed for the removal of the polymeric additives from the
as-formed FEF construct. The objective was to completely remove the binder by thermal
decomposition prior to sintering of the glass particles. Incomplete removal of the binder prior to
sintering resulted in scaffolds with a black color, due to residual carbon entrapped in the glass. A
schedule lasting 5 days, consisting of a slow heating rate (3−5°C/h) and several isothermal
holding stages, resulted in complete removal of the binder. Following the binder removal
schedule, the construct was sintered in air for 1 h at 700°C (heating rate = 5°C/min) to densify
the glass phase.
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2.4. Structural and mechanical evaluation of 13-93 bioactive glass scaffolds
Following the sintering step, bioactive glass scaffolds were ground to form a powder
(<45 µm) and analyzed using X-ray diffraction, XRD (Model D/mas 2550 v; Rigaku, The
Woodlands, TX). The analysis was performed using Cu Kα radiation (λ = 0.15406 nm) at a
scanning rate of 0.01° 2θ/min in the range 3−90° 2θ. The microstructure of the scaffold and the
glass phase was examined using conventional methods in an optical microscope and a scanning
electron microscope, SEM (S-4700; Hitachi, Japan).
The mechanical response of the fabricated scaffolds in compression was measured at a
crosshead speed of 0.2 mm/min in an Instron machine (Model 4205; Instron, Norwood, MA). Six
cube-shaped samples (5 mm in length), surface ground using a diamond coated wheel and
sectioned using a diamond-coated blade from the fabricated scaffolds, were tested. The
compression force was applied along the thickness direction of the scaffold.

2.5. Cell culture
The ability of the fabricated scaffolds to support the proliferation of MLO-A5 cells, an
established murine osteogenic cell line, was used to confirm their biocompatibility. The MLOA5 cells were kindly provided by Professor Lynda F. Bonewald, University of Missouri-Kansas
City. After they were washed twice with water and dried, cube-shaped scaffolds (5 mm in
length), similar to those used the mechanical tests described above, were sterilized by heating for
2 h at 500°C, seeded with 50,000 MLO-A5 cells suspended in 100 µl of complete medium and
incubated for 4 h to permit cell attachment. The cell-seeded scaffolds were then transferred to a
24-well plate containing 2 ml of complete medium per well. All cell cultures were maintained at
37 ºC in a humidified atmosphere of 5% CO2, with the medium changed every 2 days.

939

To visualize the metabolically active cells on and within the scaffolds, each cell-seeded
scaffold was placed in 0.2 ml serum-free medium containing 0.1 mg of the tetrazolium salt MTT
for the last 4 h of incubation. After incubation, the scaffolds were briefly rinsed in PBS, blotted,
and allowed to dry. Images of the scaffolds were obtained using a stereomicroscope fitted with a
digital camera to qualitatively assess the distribution of insoluble purple formazan, a product of
mitochondrial reduction of MTT by viable cells.

3. Results and Discussion
3.1. Structural characteristics of bioactive glass scaffolds
Figure 2 shows optical images of 13-93 bioactive glass constructs, as-formed by the FEF
technique (Figure 2a), and after sintering at 700°C (Figure 2b). The as–formed construct
(approximately 36 mm × 30 mm × 6 mm thick) was obtained by extrusion of the paste thorough
an orifice of diameter 580 µm. The diameter of the deposited filaments (∼600 µm) was slightly
larger than the diameter of the orifice due to expansion of the plastic paste upon extrusion. As
shown, the width of the pores in the plane of the deposition was ∼500 µm and the porosity of the
as-formed FEF construct was ~75% (including the porosity of the glass filaments).
There was no measurable shrinkage of the FEF scaffold during the freeze drying step,
and the shrinkage during the binder burnout step was small (linear shrinkage <3%). However, the
construct shrank considerably during the sintering step, as a result of the densification of the
network of fine glass particles. The linear shrinkage was ~28% in the plane of deposition, and
∼20% in the thickness direction of the scaffold. The sintered scaffolds consisted of glass
filaments with a thickness of ∼300 µm, porosity of ~50%, and pore width (in the plane of the
deposition) of 300 µm (Table II).
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Figure 2. Optical images showing a bioactive glass construct (a) as-formed by the FEF
technique, and (b) after binder burnout and sintering.
Table II. Structural characteristics of bioactive glass scaffolds as-formed by FEF and after
sintering at 700°C.
Parameter

FEF scaffold

Sintered scaffold

Filament diameter (µm)

600

300

*

Porosity (%)

75

Pore width (µm)

500

50
300

*Porosity including the porosity in the filaments before sintering

As Figure 2 shows, the FEF construct retained its shape and architecture during the postprocessing steps (freeze drying, binder burnout; sintering). SEM images of fractured cross
sections (Figure 3) showed that sintering resulted in almost complete densification of the glass
phase, and the glass network contained only a few fine, isolated pores. Furthermore, there was
good bonding between the adjacent layers of the sintered scaffold. These structural
characteristics are desirable for enhancing the overall strength of the sintered scaffold. The
ability to achieve nearly full density presumably resulted from the fine particle size of the
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starting glass particles (<3 µm), the homogeneous mixing of the particles and binder phase in the
paste used in the extrusion, and high packing density of the glass particles in the paste.
Figure 3a shows that the pore width (100−150 µm) in the thickness direction of the
sintered scaffold was smaller than that in deposition plane (~300 µm). This smaller pore width in
the thickness direction resulted presumably from deformation due to gravitational effects during
the FEF step and particularly during the sintering step. In sintering, the reduction in the viscosity
of the glass, necessary to achieve viscous flow densification of the glass phase and bonding
between adjacent layers of the scaffold, also enhanced deformation of the glass by creep under
the force of gravity.

Figure 3. SEM images of the fractured cross section of a sintered bioactive glass scaffold
showing (a) good bonding between adjacent layers of the scaffold, and (b) almost full
densification of the glass phase. (The section was along the thickness direction of the scaffold.)
X-ray analysis of the sintered scaffolds did not show any diffraction peaks (Figure 4).
Instead, the XRD pattern showed a broad band (centered at ∼30° 2θ) characteristic of a glass.
The ability to avoid crystallization of the bioactive glass during the scaffold fabrication process
is beneficial for achieving high density of the glass network in the scaffold (and, hence for
achieving high strength) and for maintaining the bioactive potential of the glass. Crystallization
during sintering leads to a glass−ceramic material which is often difficult to densify. Furthermore,

942

while the glass−ceramic still retains the ability to form a hydroxyapatite surface layer, the rate of
formation of the hydroxyapatite layer is markedly reduced.

Figure 4. X-ray diffraction pattern of sintered bioactive glass scaffold, showing that the glass
remained amorphous after the sintering step.
3.2. Mechanical response of sintered bioactive glass scaffolds
Figure 5a shows cube-shaped samples that were used in tests to measure the mechanical
response of the sintered scaffolds in compression. The scaffolds showed a brittle response,
typical of dense ceramics and glass (Figure 5b). The applied compressive stress increased almost
linearly with the deformation until the sample failed in a catastrophic manner into several pieces.
For the 6 samples tested, the compressive strength of the scaffold was 140 ± 70 MPa. This
average strength is in the range of values reported for human cortical bone (120−180 MPa). The
large standard deviation in the compressive strength may result from sample non-uniformity due
to the small size of the samples tested and from macroscopic flaws arising from the FEF process.
Since the linear dimension of the samples was 5 mm, variable in the sample uniformity can have
a marked effect on the mechanical properties. The elastic modulus of the samples, determined
from the slope of the stress vs. strain data, was 5−6 GPa, which is lower than the elastic modulus
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of cortical bone (10−20 GPa).

Figure 5. (a) Cube-shaped samples (5 mm in length) used in mechanical testing; (b) mechanical
response (applied stress vs. deformation) of a sample in compression.
Table III shows a comparison of the compressive strengths of biodegradable polymer,
bioactive glass, and hydroxyapatite scaffolds prepared by various methods [30]. The values
shown in Table III are not meant to be exhaustive. Instead, they show the results of selected
studies for various biomaterials and scaffold fabrication techniques. Although the compressive
944

strength in the present study showed a large standard deviation, the lowest strength (60 MPa) is
still far higher than the strengths of biodegradable polymer scaffolds, as well as bioactive glass
and hydroxyapatite scaffolds prepared by more conventional methods.

Table III. Summary of pore characteristics and compressive strength of scaffolds fabricated by a
variety of methods [30].
Technique
Freeze casting
TIPS

Polymer sponge

Gel casting
SFF
Slip casting
Gas foaming
Fiber compacting

Material
HA
HA
HA
PLLA/HA(50:50)
PLGA
PDLLA/Bioglass®
PLGA
HA/Collagen
HA
Glass reinforced HA
HA
45S5 Bioglass®
Ca2MgSi2O7
HA
HA
PCL
HA
HA
13-93 glass
HA
PLGA
HA

Open Porosity
(%)
47-52
50-65
40-65
90
93-94
93.5-94
90-96
95
86
85-97.5
70-77
89-92
63-90
76-80
72-90
61
35
41
40-45
85
85-96
13-33

Pore Size or
Dimension (µm)
5-30
80-110
20
50-200
50-60
114-137
200-500
420-560
420-560
200-400
510-720
300-500
20-1000
17-122
360 × 430 × 620
334 × 469
250-350
100-300
200-500
193-439
500-500

Compressive
Strength (MPa)
12-18
7.5-20
40-145
0.4
0.38-0.58
0.07-0.08
0.2-0.9
0.03
0.21
0.01-0.175
0.55-5
0.27-0.42
0.53-1.13
4.4-7.4
1.6-5.8
3.1
30
34
21-23
1.09-1.76
0.16-0.29
6-13

3.3 Biocompatibility of sintered bioactive glass scaffolds
Photographic images of scaffolds seeded with MLO-5A cells, cultured for 2, 4, and 6
days, and treated with MTT during the last 4 h of incubation are shown in Figure 6. The purple
pigment visible on the scaffold is an indication of viable cells, and is the result of mitochondrial
reduction of MTT to an insoluble formazan product. The increase in the intensity of the purple
color with time indicated the proliferation of viable, metabolically active cells on the scaffolds.
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Figure 6. Optical images showing cell-seeded bioactive glass scaffolds treated with MTT after
culture intervals of (a) 2 days; (b) 4 days, and (c) 6 days. The increase in intensity of the purple
color (arrow) indicates the ability of the scaffolds to support cell proliferation.
The present work shows promising results for using the FEF technique in the fabrication
of bioactive glass scaffolds for the repair and regeneration of load bearing bones. In addition to
the benefit of other SFF methods in producing articles with predesigned external shape and
internal architecture, the FEF was shown to produce porous 3D scaffolds with an almost fully
dense glass network, which resulted in a compressive strength comparable to that of cortical
bone.

4. Conclusions
The present results showed the feasibility of a freeze extrusion fabrication (FEF)
technique for creating bioactive glass scaffolds with the requisite pore architecture and
mechanical strength for potential application in the repair and regeneration of load-bearing bones.
An extrudable paste was developed for the production of scaffolds with uniform shape and
internal architecture. The scaffolds retained their external shape and internal architecture during
the FEF process, as well as during the post-processing steps (freeze drying; binder removal;
sintering). Sintered scaffolds of 13-93 glass with a porosity of ∼50%, and interconnect pores of
size 300 × 300 × 100−150 µm, had a compressive strength of 140 ± 70 MPa, comparable to the
946

strength of human cortical bone. These sintered scaffolds showed a brittle mechanical response
in which the stress increased linearly with deformation until catastrophic failure. The scaffolds
remained amorphous after sintering, and supported the proliferation of osteogenic MLO-A5 cells,
showing their biocompatibility.
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